Literature DB >> 12127311

Quality control of polyvalent pneumococcal polysaccharide-protein conjugate vaccine by nephelometry.

Chi Jen Lee1.   

Abstract

A nephelometric method was used for quantitative analysis of individual polysaccharides (PSs) in a polyvalent pneumococcal conjugate vaccine using CRM(197) as carrier protein. Using this method, the individual types 4, 6B, 9V, 14, 18C, 19F and 23F PSs were found to range between 82.3 to 119% of the manufacturer's indicated values. During conjugation using reductive amination, pneumococcal PS was first oxidized to introduce aldehyde groups. Higher or lower levels of antigen-antibody reaction were observed in periodate activated and then reduced PS of some serotypes compared to non-treated PS. Use of oxidized and reduced PS may provide an early indication of change in conjugation process. Furthermore, since the final monovalent and polyvalent conjugate vaccines gradually change during the storage period, the nephelometry provides an useful analytical method for stability study of these vaccines. Copyright 2002 The International Association for Biologicals. Published by Elsevier Science Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12127311     DOI: 10.1006/biol.2001.0320

Source DB:  PubMed          Journal:  Biologicals        ISSN: 1045-1056            Impact factor:   1.856


  4 in total

1.  Impact of the conjugation method on the immunogenicity of Streptococcus pneumoniae serotype 19F polysaccharide in conjugate vaccines.

Authors:  Jan Poolman; Carl Frasch; Anu Nurkka; Helena Käyhty; Ralph Biemans; Lode Schuerman
Journal:  Clin Vaccine Immunol       Date:  2010-12-01

Review 2.  Expanding the role of bacterial vaccines into life-course vaccination strategies and prevention of antimicrobial-resistant infections.

Authors:  Jan T Poolman
Journal:  NPJ Vaccines       Date:  2020-09-11       Impact factor: 7.344

3.  Characterization and biological activity of Taishan Pinus massoniana pollen polysaccharide in vitro.

Authors:  Shifa Yang; Kai Wei; Fengjuan Jia; Xue Zhao; Guolin Cui; Fanxia Guo; Ruiliang Zhu
Journal:  PLoS One       Date:  2015-03-17       Impact factor: 3.240

Review 4.  Extraintestinal Pathogenic Escherichia coli, a Common Human Pathogen: Challenges for Vaccine Development and Progress in the Field.

Authors:  Jan T Poolman; Michael Wacker
Journal:  J Infect Dis       Date:  2015-09-02       Impact factor: 5.226

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.